CCS HCS SB 407 -- CANCER SCREENINGS

Current law requires health insurers to provide coverage to
cancer patients for routine patient costs incurred as a result of
drugs and devices used in clinical trials, even if those drugs
and devices have not been approved by the United States Food and
Drug Administration for use in treating the patient's particular
condition.  This bill clarifies that accident-only policies,
specified disease policies, Medicare supplement policies, and
other types of limited benefit health insurance policies are
exempt from this mandate.

Missouri House of Representatives
Last Updated July 25, 2003 at 10:13 am